Opaleye Management Inc. Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$376.1B
Holdings
46
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (46 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HROWHARROW HEALTH INC | 3,820,000 | $42.8B | 11.38% | |
| 2 | TGTXTG THERAPEUTICS INC | 2,215,000 | $37.8B | 10.06% | |
| 3 | SLRNACELYRIN INC | 4,146,138 | $30.9B | 8.22% | |
| 4 | RYTMRHYTHM PHARMACEUTICALS INC | 610,000 | $28.0B | 7.46% | |
| 5 | OCULOCULAR THERAPEUTIX INC | 6,070,000 | $27.1B | 7.20% | |
| 6 | CPRXCATALYST PHARMACEUTICALS INC | 1,257,200 | $21.4B | 5.70% | |
| 7 | KROSKEROS THERAPEUTICS INC | 357,500 | $14.2B | 3.78% | |
| 8 | IDYAIDEAYA BIOSCIENCES INC | 311,500 | $11.1B | 2.95% | |
| 9 | ETONETON PHARMACEUTICALS INC | 2,529,887 | $11.1B | 2.95% | |
| 10 | CRNXCRINETICS PHARMACEUTICALS INC | 307,500 | $10.9B | 2.91% | |
| 11 | ARVNARVINAS INC | 263,700 | $10.9B | 2.89% | |
| 12 | CDXSCODEXIS INC | 3,045,525 | $9.3B | 2.47% | |
| 13 | BHVNBIOHAVEN LTD | 200,000 | $8.6B | 2.28% | |
| 14 | EWTXEDGEWISE THERAPEUTICS INC | 699,000 | $7.6B | 2.03% | |
| 15 | IOVAIOVANCE BIOTHERAPEUTICS INC | 897,000 | $7.3B | 1.94% | |
| 16 | ARQTARCUTIS BIOTHERAPEUTICS INC | 1,960,000 | $6.3B | 1.68% | |
| 17 | FDMT4D MOLECULAR THERAPEUTICS INC | 308,500 | $6.3B | 1.66% | |
| 18 | MRNS*MARINUS PHARMACEUTICALS INC | 563,500 | $6.1B | 1.63% | |
| 19 | PCVXVAXCYTE INC | 90,000 | $5.7B | 1.50% | |
| 20 | LQDALIQUIDIA CORPORATION | 445,000 | $5.4B | 1.42% | |
| 21 | TARAPROTARA THERAPEUTICS INC | 2,692,594 | $5.0B | 1.34% | |
| 22 | URGNUROGEN PHARMA LTD | 320,000 | $4.8B | 1.28% | |
| 23 | XOMAXOMA CORP DEL | 250,000 | $4.6B | 1.23% | |
| 24 | APLTAPPLIED THERAPEUTICS | 1,092,500 | $3.7B | 0.97% | |
| 25 | RLMDRELMADA THERAPEUTICS INC | 877,000 | $3.6B | 0.97% | |
| 26 | TRVITREVI THERAPEUTICS INC | 2,535,000 | $3.4B | 0.90% | |
| 27 | JSPRJASPER THERAPEUTICS INC | 3,985,340 | $3.1B | 0.84% | |
| 28 | NTLAINTELLIA THERAPEUTICS INC | 99,000 | $3.0B | 0.80% | |
| 29 | NAMSNEWAMSTERDAM PHARMA COMPANY | 265,388 | $3.0B | 0.79% | |
| 30 | GOSS 5 06/01/27GOSSAMER BIO INC | 8,000,000 | $2.9B | 0.78% | |
| 31 | LRMRLARIMAR THERAPEUTICS INC | 623,500 | $2.8B | 0.75% | |
| 32 | BDSXBRIDGEBIO PHARMA INC | 70,000 | $2.8B | 0.75% | |
| 33 | VTYXVENTYX BIOSCIENCES INC | 1,140,000 | $2.8B | 0.75% | |
| 34 | SYRSSYROS PHARMACEUTICALS INC | 359,370 | $2.8B | 0.74% | |
| 35 | GOSSGOSSAMER BIO INC | 2,982,200 | $2.7B | 0.72% | |
| 36 | PTGXPROTAGONIST THERAPEUTICS INC | 112,700 | $2.6B | 0.69% | |
| 37 | KALVKALVISTA PHARMACEUTICALS INC | 150,000 | $1.8B | 0.49% | |
| 38 | VSTMVERASTEM INC | 211,400 | $1.7B | 0.46% | |
| 39 | NYXHNYXOAH S A | 344,800 | $1.6B | 0.43% | |
| 40 | MOR2MORPHOSYS AG | 145,000 | $1.4B | 0.38% | |
| 41 | PGENPRECIGEN INC | 1,012,500 | $1.4B | 0.36% | |
| 42 | STROSUTRO BIOPHARMA INC | 301,491 | $1.3B | 0.34% | |
| 43 | CNTXCONTEXT THERAPEUTICS INC | 975,000 | $1.1B | 0.29% | |
| 44 | FULCFULCRUM THERAPEUTICS INC | 130,000 | $877.5M | 0.23% | |
| 45 | ALGSALIGOS THERAPEUTICS INC | 1,297,000 | $861.2M | 0.23% | |
| 46 | BDSXBIODESIX | 426,500 | $784.8M | 0.21% | |
| 47 | KNSAKINIKSA PHARMACEUTICALS LTD | 37,500 | $640.2M | 0.17% |